Literature DB >> 28943284

Evaluating oral flavorant effects on nicotine self-administration behavior and phasic dopamine signaling.

Robert J Wickham1, Eric J Nunes2, Shannon Hughley2, Phillip Silva1, Sofia N Walton2, Jinwoo Park3, Nii A Addy4.   

Abstract

Understanding how tobacco product flavor additives, such as flavorants in electronic cigarettes, influence smoking behavior and addiction is critical for informing public health policy decisions regarding tobacco product regulation. Here, we developed a combined intraoral (i.o.) and intravenous (i.v.) self-administration paradigm in rats to determine how flavorants influence self-administration behavior. By combining i.o. flavorant delivery with fast scan cyclic voltammetry (FSCV) or i.v. nicotine self-administration in adult, male rats, we examined whether flavors alter phasic dopamine (DA) signaling and nicotine self-administration. Oral administration of 10% sucrose or 0.32% saccharin, but not 0.005% menthol, increased phasic DA release in the nucleus accumbens (NAc). Oral sucrose or saccharin, when combined with i.v. nicotine delivery, also led to increased self-administration behavior. Specifically, combined i.o. sucrose and i.v. nicotine decreased responding compared to sucrose alone, and increased responding compared to nicotine alone. In contrast, i.o. flavorants did not alter motivational breakpoint in a progressive ratio task. Oral menthol, which did not alter i.v. nicotine administration, reversed oral nicotine aversion (50 and 100 mg/L) in a two-bottle choice test. Here, we demonstrate that i.o. appetitive flavorants that increase phasic DA signaling also increase self-administration behavior when combined with i.v. nicotine delivery. Additionally, oral menthol effects were specific to oral nicotine, and were not observed with i.v. nicotine-mediated reinforcement. Together, these preclinical findings have important implications regarding menthol and sweet flavorant additive effects on tobacco product use and can be used to inform policy decisions on tobacco product flavorant regulation.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Menthol; Nucleus accumbens; Progressive ratio; Saccharin; Sucrose; Voltammetry

Mesh:

Substances:

Year:  2017        PMID: 28943284      PMCID: PMC5714675          DOI: 10.1016/j.neuropharm.2017.09.029

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  46 in total

1.  Rank estimation and the multivariate analysis of in vivo fast-scan cyclic voltammetric data.

Authors:  Richard B Keithley; Regina M Carelli; R Mark Wightman
Journal:  Anal Chem       Date:  2010-07-01       Impact factor: 6.986

2.  Enhancing effect of menthol on nicotine self-administration in rats.

Authors:  Lisa Biswas; Erin Harrison; Yongzhen Gong; Ramachandram Avusula; Jonathan Lee; Meiyu Zhang; Thomas Rousselle; Janice Lage; Xiu Liu
Journal:  Psychopharmacology (Berl)       Date:  2016-07-29       Impact factor: 4.530

3.  Oral self-administration of sweetened nicotine solutions by rats.

Authors:  A Smith; D C Roberts
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

4.  Assessing the effects of chronic sazetidine-A delivery on nicotine self-administration in both male and female rats.

Authors:  Joshua E Johnson; Susan Slade; Corinne Wells; Ann Petro; Hannah Sexton; Amir H Rezvani; Milton L Brown; Mikell A Paige; Brian E McDowell; Yingxian Xiao; Kenneth J Kellar; Edward D Levin
Journal:  Psychopharmacology (Berl)       Date:  2012-07       Impact factor: 4.530

5.  Menthol Alone Upregulates Midbrain nAChRs, Alters nAChR Subtype Stoichiometry, Alters Dopamine Neuron Firing Frequency, and Prevents Nicotine Reward.

Authors:  Brandon J Henderson; Teagan R Wall; Beverley M Henley; Charlene H Kim; Weston A Nichols; Ruin Moaddel; Cheng Xiao; Henry A Lester
Journal:  J Neurosci       Date:  2016-03-09       Impact factor: 6.167

6.  Nicotine maintains robust self-administration in rats on a limited-access schedule.

Authors:  W A Corrigall; K M Coen
Journal:  Psychopharmacology (Berl)       Date:  1989       Impact factor: 4.530

7.  Varenicline dose dependently enhances responding for nonpharmacological reinforcers and attenuates the reinforcement-enhancing effects of nicotine.

Authors:  Melissa E Levin; Matthew T Weaver; Matthew I Palmatier; Anthony R Caggiula; Alan F Sved; Eric C Donny
Journal:  Nicotine Tob Res       Date:  2011-10-12       Impact factor: 4.244

8.  Flavored tobacco product use among U.S. young adults.

Authors:  Andrea C Villanti; Amanda Richardson; Donna M Vallone; Jessica M Rath
Journal:  Am J Prev Med       Date:  2013-04       Impact factor: 5.043

9.  Menthol suppresses nicotinic acetylcholine receptor functioning in sensory neurons via allosteric modulation.

Authors:  M Hans; M Wilhelm; D Swandulla
Journal:  Chem Senses       Date:  2012-01-25       Impact factor: 3.160

10.  Menthol Enhances Nicotine Reward-Related Behavior by Potentiating Nicotine-Induced Changes in nAChR Function, nAChR Upregulation, and DA Neuron Excitability.

Authors:  Brandon J Henderson; Teagan R Wall; Beverley M Henley; Charlene H Kim; Sheri McKinney; Henry A Lester
Journal:  Neuropsychopharmacology       Date:  2017-04-02       Impact factor: 7.853

View more
  19 in total

1.  Flavor-specific enhancement of electronic cigarette liquid consumption and preference in mice.

Authors:  A L Wong; S M McElroy; J M Robinson; S M Mulloy; F K El Banna; A C Harris; M G LeSage; A M Lee
Journal:  Drug Alcohol Depend       Date:  2020-04-25       Impact factor: 4.492

2.  Status and Future Directions of Preclinical Behavioral Pharmacology in Tobacco Regulatory Science.

Authors:  Mark G LeSage; John R Smethells; Andrew C Harris
Journal:  Behav Anal (Wash D C)       Date:  2018-07-09

3.  Why flavored vape products may be attractive: Green apple tobacco flavor elicits reward-related behavior, upregulates nAChRs on VTA dopamine neurons, and alters midbrain dopamine and GABA neuron function.

Authors:  Alicia J Avelar; Austin T Akers; Zachary J Baumgard; Skylar Y Cooper; Gabriella P Casinelli; Brandon J Henderson
Journal:  Neuropharmacology       Date:  2019-07-29       Impact factor: 5.250

Review 4.  History repeats itself: Role of characterizing flavors on nicotine use and abuse.

Authors:  Theresa Patten; Mariella De Biasi
Journal:  Neuropharmacology       Date:  2020-06-01       Impact factor: 5.250

5.  Menthol blunts the interoceptive discriminative stimulus effects of nicotine in female but not male rats.

Authors:  Y Wendy Huynh; Anthony Raimondi; Andrew Finkner; Jordan D Kuck; Carly Selleck; Rick A Bevins
Journal:  Psychopharmacology (Berl)       Date:  2020-05-24       Impact factor: 4.530

6.  Impact of menthol on nicotine intake and preference in mice: Concentration, sex, and age differences.

Authors:  Deniz Bagdas; Asti Jackson; Moriah Carper; Rita Yu-Tzu Chen; Lois S Akinola; M Imad Damaj
Journal:  Neuropharmacology       Date:  2020-08-20       Impact factor: 5.250

7.  Acute effects of inhaled menthol on the rewarding effects of intravenous nicotine in smokers.

Authors:  Gerald W Valentine; Elise E DeVito; Peter I Jatlow; Ralitza Gueorguieva; Mehmet Sofuoglu
Journal:  J Psychopharmacol       Date:  2018-05-23       Impact factor: 4.153

8.  Evaluation of reinforcing and aversive effects of voluntary Δ9-tetrahydrocannabinol ingestion in rats.

Authors:  Daniel G Barrus; Timothy W Lefever; Jenny L Wiley
Journal:  Neuropharmacology       Date:  2018-05-03       Impact factor: 5.250

9.  Effect of menthol on nicotine intake and relapse vulnerability in a rat model of concurrent intravenous menthol/nicotine self-administration.

Authors:  Tanseli Nesil; Syeda Narmeen; Anousheh Bakhti-Suroosh; Wendy J Lynch
Journal:  Psychopharmacology (Berl)       Date:  2018-11-27       Impact factor: 4.530

10.  Menthol facilitates dopamine-releasing effect of nicotine in rat nucleus accumbens.

Authors:  Meiyu Zhang; Erin Harrison; Lisa Biswas; Thuy Tran; Xiu Liu
Journal:  Pharmacol Biochem Behav       Date:  2018-09-08       Impact factor: 3.533

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.